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SUMMARY
Aim: The objective was to describe an outbreak of bloodstream infections by Burkholderia cepacia complex (Bcc) in bone marrow 
transplant and hematology outpatients. Methods: On February 15, 2008 a Bcc outbreak was suspected. 24 cases were identified. 
Demographic and clinical data were evaluated. Environment and healthcare workers’ (HCW) hands were cultured. Species were 
determined and typed. Reinforcement of hand hygiene, central venous catheter (CVC) care, infusion therapy, and maintenance of 
laminar flow cabinet were undertaken. 16 different HCWs had cared for the CVCs. Multi-dose heparin and saline were prepared on 
counter common to both units. Findings:14 patients had B. multivorans (one patient had also B. cenopacia), six non-multivorans Bcc 
and one did not belong to Bcc. Clone A B. multivorans occurred in 12 patients (from Hematology); in 10 their CVC had been used on 
February 11/12. Environmental and HCW cultures were negative. All patients were treated with meropenem, and ceftazidime lock-
therapy. Eight patients (30%) were hospitalized. No deaths occurred. After control measures (multidose vial for single patient; CVC 
lock with ceftazidime; cleaning of laminar flow cabinet; hand hygiene improvement; use of cabinet to store prepared medication), 
no new cases occurred. Conclusions: This polyclonal outbreak may be explained by a common source containing multiple species 
of Bcc, maybe the laminar flow cabinet common to both units. There may have been contamination by B. multivorans (clone A) of 
multi-dose vials.
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INTRODUCTION
Burkholderia cepacia complex (Bcc) comprises at least 15 different 
species or genomovars based on phenotypic and genotypic analyses16,17. 
Identification to species level has been troublesome in the clinical 
laboratory. Automated methods seem to perform poorly in identifying 
species of Bcc19,25. Molecular methods are more appropriate8,12,16. 
Clinically, Bcc mainly cenocepacia and multivorans species are important 
colonizers and cause respiratory tract illness among cystic fibrosis 
patients1. In the hospital, the importance of Bcc is due to its potential 
to spread from person to person and to survive in moist environments. 
Multiple healthcare-associated outbreaks have been described involving 
contaminated water11, prefabricated moist washcloths13, contaminated 
medication14, nebulization solution15, antiseptic solution9, heparin24, 
moisturizing body milk2, mouthwash solution1. We report here an 
outbreak involving different species of Bcc and the dissemination of a 
predominant clone suggesting heavy contamination by a common source.
METHODS
The outbreak occurred in Hospital das Clínicas, a 2000-bed hospital 
affiliated to the University of São Paulo, during the period from January 
1 to February 29, 2008. The hospital is divided into six institutes and 
transfer of patients between institutes occurs. The outbreak involved two 
outpatient units: one for patients with hematological malignancies and 
the other for bone marrow transplant patients. These units were adjacent 
and independent but shared one room which contained a laminar flow 
cabinet used to prepare chemotherapy and a counter used to prepare 
intravenous medication. In these units, the patients were admitted for 
a few hours at a time and received medication including intravenous 
therapy such as chemotherapy, antimicrobial drugs and hydration through 
central venous catheters.
The outbreak of bacteremia caused by B. cepacia was suspected on 
February 15, 2008 and an investigation was triggered. A case was defined as 
a patient with B. cepacia bacteremia occurring in January or February, 2008 
who received care or medication prepared in these units. An evaluation of all 
positive blood cultures in patients hospitalized in the entire hospital during 
these two months and during the previous 12 months was also undertaken. 
Visits to both affected outpatient units were made for evaluation.
The hospital records of all case patients were evaluated and the 
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following factors were recorded: sex; age; underlying diseases; the 
presence and the type of central venous catheter (CVC), insertion date, 
type of dressing used (gauze or transparent), type of antiseptic used 
during CVC handling; the use of IV medications, including heparin, and 
of blood products; the use of chemotherapy; dates of the last three uses 
of the CVC before the first positive culture and the healthcare workers 
who had cared for each patient. Cases were treated with meropenem.
Infection Control Measures: Two visits on different days and 
meetings with all the staff of the affected units were held in order to 
evaluate practices in infection control and managing of infusion therapy. 
The main findings were the following:
- Multi-dose heparin, methylprednisolone and saline solution for 
intravenous infusion were routinely used. The containers and vials 
were not left with needles inserted in them but it was not clear how 
many patients used each vial nor was there a control of when they 
should be discarded. These multi-use items were placed on the shared 
counter;
- Nurses frequently prepared prescribed medications in the morning 
for use during the whole day in order to “save time”;
- Syringes with aspirated solution without identification (patient name, 
type of solution or time of preparation) were placed on the counter 
and used for flushing catheters during the day;
- There was no exclusive sink inside the room used for the preparation 
of infusion therapy;
- There were empty vials of alcohol-based solution for hand hygiene;
- There was no evidence of systematic cleaning of the laminar flow 
cabinet and the refrigerator used for medication storage as well as 
controls of refrigerator temperature;
- There was no evidence of systematic cleaning of surfaces with a 
disinfectant product.
Based on these findings, the following control measures were 
implemented:
- Heparin, methylprednisolone and hydrocortisone vials were defined 
for a single patient and each vial received a label with the patient’s 
name;
- Syringes with medication were left in the laminar flow cabinet until 
the moment of administration to patient and medication other than 
chemotherapy was to be prepared immediately before administration;
- Batches of antiseptic chlorhexidine (soap and alcohol-based) were 
replaced;
- Cleaning of laminar flow cabinet and control of temperature of 
refrigerators were reinforced;
- Cleaning of the areas in which medication was prepared with a 
chlorine-based product was reinforced;
- Hand hygiene was emphasized and the number of alcohol rub 
dispensers in the units was increased;
- Blood cultures of all patients with a CVC that had been handled in 
the affected units during the outbreak period were collected;
- Lock with ceftazidime for all long-term CVCs was instituted;
- Active surveillance for new cases was implemented.
Microbiologic study: The following items were cultured between 
February 21 and 28:
- Swabs from taps, sink drains, counters, laminar flow cabinet and 
healthcare workers hands (nurses, pharmacists) and other patients in 
direct contact with cases. Swabs were plated on BCSA (Burkholderia 
cepacia selective agar) and then inoculated in a 600,000 UI/L 
polymyxin B, vancomycin 2.5 mg/L and gentamicin 10 mg/L BHI 
broth (brain heart infusion). They were incubated at 10-32 °C up to 
seven days. Growing colonies were then submitted to Gram staining. 
Glucose fermenting was tested by OF (oxidation-fermentation) 
open and closed tubes and oxidase tests. After non-fermenting 
confirmation, biochemical tests for B. cepacia complex identification 
were performed: OF-glucose, OF-maltose, OF-xylose, OF-lactose, 
OF-sucrose and/or lysine decarboxylation;
- Water samples were collected (1 L of both cold and hot water) in 
sterile containers. Samples were divided into two aliquots of 500 
mL each and filtered in an acetate cellulose membrane with 0.25 µm 
pores and then plated on BCSA and MacConkey agar.
The hospital’s clinical microbiology laboratory used an automatized 
system for identification (Vitek, bioMerrieux). Reidentification of B. 
cepacia isolates was performed using the phenotypic method API ® 20 
NE (bioMérieux SA, Lyon, France). The isolates that were phenotypically 
defined as belonging to the B. cepacia complex were submitted to 
molecular identification using multiplex polymerase chain reaction 
with the primers and technique as described elsewhere12. The fur gene 
was amplified for various strains using primers JD490 and JD491 and 
the DNA sequences were determined by direct sequencing from the 
amplicons using the MegaBACE 1000 DNA Sequencer. The sequences 
were analyzed using the software Sequence Analyzer with the Base Caller 
Cimarron 3.12 and compared with those in GenBank (www.ncbi.nlm.
nih.gov). This method can identify the following species: B. cepacia, B. 
multivorans, B. cenocepacia, B. dolosa, B. vietnamiensis, B. ambifaria, 
B. stabilis, B. antina, Bcc group K and B. pyrrocinia. Isolates were typed 
using pulsed-field gel electrophoresis (PFGE)18 using the restriction 
enzyme SpeI and interpreted according to criteria by TENOVER et al.20 . 
Minimum inhibitory concentrations (MIC) for ceftazidime, meropenem, 
minocycline, levofloxacin and sulfamethoxazole-trimethoprim were 
determined and interpreted using the agar microdilution technique4.
RESULTS
Based on the case definition, 27 patients were identified but we could 
only retrieve clinical information pertaining to 24 due to failure to retrieve 
complete records for three patients. Revision of the infection control 
database could not identify any cases of bacteremia by B. cepacia from 
January through December 2007 in our hospital (Fig. 1).
The main symptoms of cases were fever, present in 21 (88%) patients, 
chills in 14 (58%), coughing in two and hypotension and septic shock in 
one patient each (Table 1). Ten patients had their CVC used on February 
11 and/or 12 and, in nine of these patients, this had been their last CVC 
use before the positive blood culture. None of the HCWs could be directly 
implicated as the source of the outbreak, especially because each HCW 
only worked in one of the affected units (Fig. 2).
Two patients were hospitalized in Hematology inpatient unit when 
they acquired the Burkholderia infection. However, they were included 
in the outbreak because they received chemotherapy prepared in the 
outpatient unit. Fifteen patients (56%) had their catheters removed, on 
average 17.8 days after the positive blood culture (range: 1-70, median: 
14). Eight patients (30%) were hospitalized, and one patient died within 
thirty days after the positive culture of causes not related to the infection.
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After the implementation of the control measures no new cases 
occurred.
None of the environmental cultures or HCW hand swabs was positive 
for Burkholderia cepacia complex.
Twenty-three isolates from 21 patients were available for molecular 
identification and typing and for determination of MICs. 14 isolates were 
identified as B. multivorans and six belonged to the B. cepacia complex 
but could not be identified to the species level. One isolate did not belong 
to the B. cepacia complex, and could not be completely identified. The 
distribution of molecular types based on PFGE can be seen in Figure 1. 
PFGE types were named A through F. The predominant type, called A 
and identified as B. multivorans, was only present starting on February 12, 
2008 and all infections occurred in patients belonging to the Hematology 
Unit. PFGE type D was B. cenocepacia and type E was B. multivorans. 
Isolates PFGE types B and C were the B. cepacia complex ones with 
Fig. 1 - Distribution of cases over time and molecular types during an outbreak of bloodstream 
infections caused by Burkholderia cepacia in two outpatient units (Hematology and Bone 
Marrow Transplant). Hospital das Clínicas, University of São Paulo, Brazil. 2007 to March, 
2008. (Only the first isolate from each patient is depicted).
Table 1
Characteristics of 24 patients involved in an outbreak of bloodstream infections 
caused by Burkholderia cepacia in two outpatient units (Hematology and Bone 
Marrow Transplant). Hospital das Clínicas, University of São Paulo, Brazil. 
January-February, 2008
Characteristics
Male sex 10 (42%)
Age (years)
     Mean (SD)




     Hematology




     Hodgkin’s lymphoma
     Non-Hodgkin’s lymphoma
     Aplastic anemia
     Chronic myelocytic leukemia
     Myelofibrosis
     Acute myelocytic leukemia
     Acute lymphocytic leukemia










     Totally implanted
     Partially implanted
13 (54%)
11 (46%)
Type of dressing used on CVC site
     Transparent film
     Gauze
17 (71%)
7 (29%)
Use of chlorhexidine at CVC site 24 (100%)
Under chemotherapy 8 (33%)
Products administered through CVC
     Heparin
     Dexamethasone
     Teicoplanin
     Ondansetron
     Cefepime
     Dipirone
     Meropenem
     Filgrastim
     Ceftriaxone
     Platelet concentrate
     Fluconazole
     Levofloxacin
     Acyclovir
     Red blood cell concentrate
















CVC was used on February 11 and/or 12, 2008 10 (42%)
Days between CVC insertion and positive blood culture1
     Mean (SD)
     Median (range)
276.5 (257)
189 (16-853)
Days between last use of CVC and positive blood culture2
     Mean (SD)
     Median (range)
6.4 (6.6)
6 (1-32)
SD: standard deviation; CVC: central venous catheter; 1 data available for 20 
patients; 2 data available for 21 patients.
Fig. 2 - Number of case patients cared for by each healthcare worker during an outbreak of 
bloodstream infections caused by Burkholderia cepacia in two outpatient units. (Hematology 
Unit: black bars; Bone Marrow Transplant Unit: grey bars). Hospital das Clínicas, University 
of São Paulo, Brazil. January-February, 2008.
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species level not identified. They only occurred during the last three days 
of the outbreak. The isolate presenting PFGE type F was the one that did 
not belong to the B. cepacia complex.
Two patients presented more than one isolate. One patient had two 
different species, initially B. multivorans (PFGE type E), and then B. 
cenocepacia 25 days after the first episode (PFGE type D). The other 
patient had two isolates with different PFGE types (B and E) that were 
identified from cultures collected five days apart.
MIC50 was 4 µg/mL; 1; 2; 2 and 1 µg/mL for ceftazidime, 
levofloxacin; minocycline, meropenem and sulfamethoxazole/
trimethoprim, respectively. MIC90 was 8 µg/mL; 16; 8; 4; and 8 µg/mL 
respectively for the same antimicrobial drugs.
DISCUSSION
Our study describes an outbreak of Burkholderia cepacia complex 
bloodstream infections in Hematologic and Bone Marrow Transplant 
outpatient units with multiple clones and species. No other cases of Bcc 
infections were diagnosed in the entire hospital during the outbreak 
period or in the previous year, fitting the definition of outbreak and 
strongly pointing to a localized problem in the two affected outpatient 
units. Although evidence points to a common source, this could not 
be completely proven and the fact that there are multiple clones and 
species makes interpretation difficult. During the entire outbreak 
period, inadequate practices in preparation and storage of intravenous 
medication probably favored contamination leading to bloodstream 
infections. This hypothesis is reinforced by the fact that two case patients 
were hospitalized and their only epidemiologic link to the other cases 
was that they had received medication prepared in the outpatient area. 
No healthcare worker could be directly implicated as the source of the 
outbreak especially because, although the unit shared areas, each worker 
belonged strictly to one of the units and there was no sharing of healthcare 
workers between the units.
We hypothesized that two distinct events took place. There seems 
to clearly have been a contamination by B. multivorans (molecular 
type A) and probably the source was the use of intravenous drugs 
or solutions prepared from multi-dose vials in the Hematology unit. 
Although we could not definitely demonstrate a common source of B. 
multivorans, the case distribution and the fact that ten patients had had 
their CVC manipulated on February 11 and/or 12 makes it probable 
that contaminated solution was administered. As there were no cases in 
other units of the hospital, contamination during industrial production 
is improbable and it must have occurred during manipulation of the 
multi-dose vials. Solutions under suspicion were saline used for central 
catheter flushing and heparin. All twelve patients who presented with 
type A-B. multivorans in blood cultures had received heparin through 
their catheters and it is not possible to ascertain whether they received 
saline from a multi-dose vial as this was not routinely registered in the 
patients’ records. Saline flushing of the CVC was a common practice in 
the units. Among the recommendations on good practices in intravenous 
therapy, multi-dose vials should be avoided and intravenous solutions 
should not be stored for long periods of time after preparation. To our 
knowledge there have not been reports of outbreaks of B. multivorans 
due to the contamination of multi-dose vials of intravenous medication 
although reports of such contamination by other agents have been 
reported. In an outbreak of CVC associated bloodstream infection by 
B. cepacia and Myroides odoratus, commercial ampoules of sterile 
water intrinsically contaminated were found to be the common source7. 
The contamination of Ringer lactate solution used as multiple-dose 
vial to flush peripheral venous catheters was the cause of an outbreak 
of bloodstream infections by clonal B. cepacia6. The contamination of 
a heparin flush solution used for catheters in an oncology unit caused 
a B. cepacia (formerly Pseudomonas cepacia) outbreak already back 
in 199121. In a systematic review of HAI related to contaminated 
substances23, Bcc ranked first as contaminating pathogen in substances 
other than blood.
The contamination of multi-dose medication does not fully 
explain the outbreak. Although most outbreaks of Bcc described have 
been clonal6,10,11, an outbreak caused by contaminated bromopride in 
2006 was shown to be polyclonal14. Bcc are bacteria largely present 
in the natural environment, such as soil, water and rhizosphere, 
which is the environment adjacent to the roots of plants22, in which 
different species may co-exist. Most species belonging to Bcc have 
also been shown to produce biofilm5 which may be important in the 
pathogenesis of human disease. Patients with cystic fibrosis have been 
described to carry different species of Bcc3. Thus it is possible that 
in the hospital, environmental contamination by Bcc be polyclonal, 
thus causing polyclonal infections. It is possible that a contaminated 
environmental source, such as the laminar flow cabinet, was involved 
in the outbreak. This cabinet was the only common feature between the 
two units and inadequate maintenance of the cabinets was observed. It 
is possible that biofilm formed within the cabinet contained multiple 
species of Burkholderia which would explain the two cases with B. 
multivorans found in BMT patients that did not belong to the same 
clone, B. cenocepacia and the cases caused by unidentified species 
of Burkholderia. Unfortunately, this is only a hypothesis as cultures 
obtained from the cabinet were negative. Measures to improve cabinet 
maintenance and cleaning were implemented among others to control 
the outbreak.
Identification to the species level of Burkholderia cepacia poses 
a problem to the clinical laboratory because phenotypical tests are 
not reliable to differentiate between species within Bcc. Reference 
laboratories are usually needed for identification that depends on 
molecular techniques. Thus, managing clinical and epidemiological 
issues, such as outbreaks, at the point of care is a problem. New methods 
that allow the search for species-specific biomarkers such as matrix-
assisted laser desorption ionization-time of flight mass spectrometry 
(MALDI-TOF MS) are promising for Bcc16. Molecular typing such as 
PFGE, used in our outbreak, matched the results of species identification. 
However typing was useless to explain the outbreak. In fact it could even 
have been misleading as finding multiple clones may have weakened the 
hypothesis of an outbreak.
A limitation of our study was that medications from multi-dose vials 
were not available for culturing and that the laminar flow cabinet was 
not entirely dismantled for culturing.
In summary, the outbreak of bloodstream infections caused by 
Burkholderia spp. was interrupted by reinforcing good practices, probably 
eliminating the contamination of multi-dose vials and the common source. 
The finding of different species was an original feature of this outbreak.
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RESUMO 
Surto policlonal de infecção de corrente sanguínea causada pelo 
complexo Burkholderia cepacia em unidades de hospital-dia de 
hematologia e transplante de medula óssea 
O objetivo foi descrever um surto de infecções da corrente sanguínea 
por complexo B. cepacia (Bcc) nos ambulatórios de hematologia e 
transplante de medula óssea. Métodos: Em 15/02/2008, um surto de Bcc 
foi suspeitado. 24 casos foram identificados. Os dados demográficos e 
clínicos foram avaliados. Mãos de profissionais da saúde e ambiente 
foram cultivadas. Espécies foram determinadas e tipadas. Reforço 
da higiene das mãos, cuidados com cateteres, terapia de infusão e 
manutenção da câmara de fluxo laminar foram realizadas. 16 profissionais 
de saúde (PS) diferentes manipularam os cateteres. Heparina multidoses 
e soro eram preparadas em um balcão comum a ambas as unidades. 
Resultados: 14 pacientes tiveram B. multivorans (um paciente teve 
também B. cenopacia), 6 Bcc não-multivorans e um teve um agente não 
pertencente a Bcc. Clone A de B. multivorans ocorreu em 12 pacientes 
(da Hematologia), em 10 o cateter havia sido utilizado nos dias 11 ou 
12 de fevereiro. Culturas ambientais e de PS foram negativos. Todos os 
pacientes foram tratados com meropenem e selo de ceftazidima. Oito 
pacientes (30%) foram hospitalizados. Não ocorreram mortes. Após as 
medidas de controle, nenhum novo caso ocorreu. Conclusões: Este surto 
policlonal pode ser explicado por uma fonte comum contendo várias 
espécies de Bcc, talvez a câmara de fluxo laminar comum a ambas as 
unidades. Pode ter havido contaminação por B. multivorans (clone A) 
de frascos multi-dose.
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